![]() |
CBL0137
- 英文名称:CBL0137
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B11072
- cas:1197996-80-7
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B11072 |
用途 | 科研检测 |
英文名称 | CBL0137 |
包装规格 | 1MG |
CAS编号 | 1197996-80-7 |
别名 | CBL0137 |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:98% by HPLC;NMR (Conforms)
分子式:C21H24N2O2
分子量:336.44
溶剂:DMSO (20 mg/ml)
性状:Pale yellow to off-white solid
存储:-20°C
Activity (short version):FACT histone chaperone inhibitor
Function / Pharmacology:CBL0137 is an anticancer agent that activates p53 and suppresses NF-kB via trapping of the FACT (facilitates chromatin transcription) complex, an important histone chaperone that mediates nucleosome disassembly and reassembly and facilitates DNA transcription, replication, and repair.1,2 Importantly, it is able to intercalate DNA and disrupt DNA/histone interactions without genotoxicity. CBL0137 inhibits the self-renewal of cancer stem cells via NOTCH1 activation.3 CBL0137 downregulation of HSF1 and MYC(N) have also been demonstrated in animal models.4,5 CBL0137 has also been shown to improve immunological tumor control via facilitating release of cytokines and chemokines attracting NK, CD8+, and CD4+ T cells.6 CBL0137 was able to activate the Z-RNA sensor ZBP1 inducing necroptosis and reversing immune checkpoint blockage unresponsiveness in mouse models of melanoma.7
分子式:C21H24N2O2
分子量:336.44
溶剂:DMSO (20 mg/ml)
性状:Pale yellow to off-white solid
存储:-20°C
Activity (short version):FACT histone chaperone inhibitor
Function / Pharmacology:CBL0137 is an anticancer agent that activates p53 and suppresses NF-kB via trapping of the FACT (facilitates chromatin transcription) complex, an important histone chaperone that mediates nucleosome disassembly and reassembly and facilitates DNA transcription, replication, and repair.1,2 Importantly, it is able to intercalate DNA and disrupt DNA/histone interactions without genotoxicity. CBL0137 inhibits the self-renewal of cancer stem cells via NOTCH1 activation.3 CBL0137 downregulation of HSF1 and MYC(N) have also been demonstrated in animal models.4,5 CBL0137 has also been shown to improve immunological tumor control via facilitating release of cytokines and chemokines attracting NK, CD8+, and CD4+ T cells.6 CBL0137 was able to activate the Z-RNA sensor ZBP1 inducing necroptosis and reversing immune checkpoint blockage unresponsiveness in mouse models of melanoma.7